- Home
- IVA vs NMI Comparison
IVA vs NMI Comparison
Compare IVA & NMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- NMI
- Stock Information
- Founded
- IVA 2011
- NMI 1988
- Country
- IVA France
- NMI United States
- Employees
- IVA N/A
- NMI N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- NMI Trusts Except Educational Religious and Charitable
- Sector
- IVA Health Care
- NMI Finance
- Exchange
- IVA Nasdaq
- NMI Nasdaq
- Market Cap
- IVA 117.3M
- NMI 96.1M
- IPO Year
- IVA 2020
- NMI N/A
- Fundamental
- Price
- IVA $2.35
- NMI $9.48
- Analyst Decision
- IVA Strong Buy
- NMI
- Analyst Count
- IVA 4
- NMI 0
- Target Price
- IVA $13.25
- NMI N/A
- AVG Volume (30 Days)
- IVA 9.3K
- NMI 28.4K
- Earning Date
- IVA 09-25-2024
- NMI 01-01-0001
- Dividend Yield
- IVA N/A
- NMI 4.10%
- EPS Growth
- IVA N/A
- NMI N/A
- EPS
- IVA N/A
- NMI N/A
- Revenue
- IVA $20,652,523.00
- NMI N/A
- Revenue This Year
- IVA N/A
- NMI N/A
- Revenue Next Year
- IVA $361.78
- NMI N/A
- P/E Ratio
- IVA N/A
- NMI N/A
- Revenue Growth
- IVA N/A
- NMI N/A
- 52 Week Low
- IVA $1.53
- NMI $8.30
- 52 Week High
- IVA $4.75
- NMI $10.05
- Technical
- Relative Strength Index (RSI)
- IVA 36.64
- NMI 42.03
- Support Level
- IVA $2.22
- NMI $9.29
- Resistance Level
- IVA $2.39
- NMI $9.67
- Average True Range (ATR)
- IVA 0.10
- NMI 0.08
- MACD
- IVA -0.03
- NMI -0.01
- Stochastic Oscillator
- IVA 24.76
- NMI 47.50
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About NMI Nuveen Municipal Income Fund Inc.
Nuveen Municipal Income Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories.